lubiprostone capsules

lubiprostone capsules
SPL v2
SPL
SPL Set ID 81f9c9de-f89d-4ab0-a8ca-18d3691e42f9
Route
oral
Published
Effective Date 2023-03-24
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
lubiprostone (8 ug)
Inactive Ingredients
1,4-sorbitan ferric oxide red ferrosoferric oxide gelatin, unspecified medium-chain triglycerides propylene glycol shellac sorbitol titanium dioxide water

Identifiers & Packaging

Pill Appearance
Imprint: 24 Shape: oval Color: pink Color: yellow Size: 9 mm Score: 1
Marketing Status
anda active Since 2023-03-23

Description

NDC 70771-1763-6 Lubiprostone Capsules, 8 mcg 60 Capsules Rx only NDC 70771-1764-6 Lubiprostone Capsules, 24 mcg 60 Capsules Rx only


Medication Information

Description

NDC 70771-1763-6 Lubiprostone Capsules, 8 mcg 60 Capsules Rx only NDC 70771-1764-6 Lubiprostone Capsules, 24 mcg 60 Capsules Rx only

Package Label.principal Display Panel

NDC 70771-1763-6

Lubiprostone Capsules, 8 mcg

60 Capsules

Rx only

NDC 70771-1764-6

Lubiprostone Capsules, 24 mcg

60 Capsules

Rx only


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 70771-1763-6

Lubiprostone Capsules, 8 mcg

60 Capsules

Rx only

NDC 70771-1764-6

Lubiprostone Capsules, 24 mcg

60 Capsules

Rx only


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)